← Back to Search

Device

Deep rTMS active + Varenicline for Smoking Cessation

N/A
Waitlist Available
Led By Bernard Le Foll, MD,PhD,MCFP
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights

Study Summary

This trial will test whether deep brain stimulation can help people quit smoking by reducing cravings and dependence.

Eligible Conditions
  • Smoking Cessation
  • Tobacco Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Point prevalence abstinence at the end of 12 weeks
Secondary outcome measures
Cigarettes per day (TLFB)
Continuous abstinence at 6 months
Expired CO Measurements
+6 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Deep rTMS active + VareniclineActive Control2 Interventions
Participants undergoing deep rTMS (active) for 4 weeks (5 sessions/week) along with 12 weeks of varenicline.
Group II: Deep rTMS sham + VareniclinePlacebo Group2 Interventions
Participants undergoing deep rTMS (sham) for 4 weeks (5 sessions/week) along with 12 weeks of varenicline.

Find a Location

Who is running the clinical trial?

PfizerIndustry Sponsor
4,567 Previous Clinical Trials
10,907,820 Total Patients Enrolled
BrainswayIndustry Sponsor
36 Previous Clinical Trials
2,598 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
354 Previous Clinical Trials
81,054 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025